ZNF217, an m6A methyltransferase inhibitor, interacts with some epigenetic regulators, activates the transcription of key pluripotency genes, regulates m6A deposition on their transcripts via sequestering METTL3 28 and is involved in the proliferation, survival and invasiveness of cancer cells.29 This evidence concerns the gene ZNF217 and cancer.